Pemphigus in elderly adults: clinical presentation, treatment, and prognosis

J Am Geriatr Soc. 2012 Jun;60(6):1185-7. doi: 10.1111/j.1532-5415.2012.03987.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Dapsone / therapeutic use
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Folic Acid Antagonists / therapeutic use
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Immunologic Factors / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Pemphigus / diagnosis*
  • Pemphigus / drug therapy*
  • Prognosis
  • Remission Induction
  • Retrospective Studies
  • Rituximab
  • Severity of Illness Index
  • Steroids / therapeutic use
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Folic Acid Antagonists
  • Immunologic Factors
  • Immunosuppressive Agents
  • Steroids
  • Rituximab
  • Hydroxychloroquine
  • Dapsone